Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters

Medical Science Monitor

Volumn 9, Issue 2, 2003, Pages

  Frauli, Mélanie ^a   Ribault, Sébastien ^a   Neuville, Pascal ^a   Augé, Fabrice ^a   Calenda, Valérie ^a  

^a TRANSGENE S A   (France)

Author keywords

enolase; Creatine kinase; Gene transfer; Ischemla; Skeletal actin

Indexed keywords

ADENOVIRUS VECTOR; ALPHA ACTIN; CREATINE KINASE; ENOLASE; LUCIFERASE; VIRUS VECTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; EXPRESSION VECTOR; FEMALE; GENE CASSETTE; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERIPHERAL ISCHEMIA; POLYMERASE CHAIN REACTION; PROMOTER REGION; REPORTER GENE; ROUS SARCOMA ONCOVIRUS; SAFETY; SKELETAL MUSCLE; TISSUE SPECIFICITY;

ACTINS; ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0037296815     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Shyu KG, Manor O, Magner M et al: Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation, 1998; 98: 2081-2087
2. Gowdak LH, Poliakova L, Li Z et al: Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model. J Vasc Surg, 2000; 32: 343-352
3. Emanueli C, Minasi A, Zacheo A et al: Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation, 2001; 103: 125-132
4. Gowdak LH, Poliakova L, Wang X et al: Adenovirus-mediated VEGF121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation, 2000; 102: 565-571
5. Baumgartner I, Pieczek RN, Manor O et al: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation, 1998; 97: 1114-1123
6. Rajagopalan S, Shah M, Luciano A et al: Adenovirus-mediated gene transfer of VEGF121 improves lower-extremity endothelial function and flow reserve. Circulation, 2001; 104: 753-755
7. Claffey KP, Brown LF, del Aguila LF et al: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res, 1996; 56: 172-181
8. Lee RJ, Springer ML, Blanco-Bose WE et al: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation, 2000; 102: 898-901
9. Guo ZS, Wang LH, Eisensmith RC, Woo SL: Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther, 1996; 3: 802-810
10. Kim S, Lin H, Barr E et al: Transcriptional targeting of replication-detective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest, 1997; 100: 1006-1014
11. Griscelli F, Gilardi-Hebenstreit P, Hanania N et al: Heart-specific targeting of b-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors. Hum Gene Ther, 1998; 9: 1919-1928
12. Barnahrt KM, Hartikka J, Manthorpe M, Norman J, Hobart P. Enhancer and promoter chimeras in plasmids designed for intramuscular injection: a comparative in vivo and in vitro study. Hum Gene Ther, 1998; 9: 2545-2553
13. Keogh MC, Chen D, Schmitt J F et al: Design of a muscle-specific expression vector utilising human vascular smooth muscle a-actin regulatory elements. Gene Ther, 1999; 6: 616-628
14. Ribault S, Neuville P, Méchine-Neuville A et al: Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res, 2001; 88: 468-475
15. Muscat GE, Kedes L: Multiple 5′-flanking regions of the human a-skeletal actin gene synergistically modulate muscle-specific expression. Mol Cell Biol, 1987; 7: 4089-4099
16. Taylor A, Erba HP, Muscat GE, Kedes L: Nucleotide sequence and expression of the human skeletal a-actin gene: evolution of functional regulatory domains. Genomics, 1988; 3: 323-336
17. Ragot T, Stratford-Perricaudet LD, Vincent N et al: Adenovirus-mediated transfer of a human dystrophin gene to skeletal muscle of mdx mouse. Gene Ther, 1994; 1(suppl)1: 53-54
18. Larochelle N, Lochmüller H, Zhao J et al: Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Ther, 1997; 4: 465-472
19. Arbuthnot PB, Bralet MP, Le Jossic C et al: In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther, 1996; 7: 1503-1514
20. Feo S, Antona V, Barbieri G et al: Transcription of the human benolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors. Mol Cell Biol, 1995; 15: 5991-6002
21. Trask RV, Koster JC, Ritchie ME, Billadello JJ: The human M creatine kinase gene enhancer contains multiple functional interacting domains. Nucleic Acids Res, 1992; 20: 2313-2320
22. De Wet JR, Wood KV, DeLuca M et al: Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol, 1987; 7: 725-737
23. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P: Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest, 1992; 90: 626-630
24. Chartier C, Degryse E, Gantzer M et al: Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol, 1996; 70: 4805-4810
25. Lusky M, Christ M, Rittner K et al: In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol, 1998; 72: 2022-2032
26. Michou AI, Santoro L, Christ M et al: Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther, 1997; 4: 473-482
27. Devlin RB, Emerson CP: Coordinate accumulation of contractile protein mRNAs during myoblast differentiation. Dev Biol, 1979; 69: 202-216
28. Hagstrom JN, Couto LB, Scallan C et al: Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood, 2000; 95: 2536-2542
29. Passantino R, Antona V, Barbieri G et al: Negative regulation of benolase gene transcription in embryonic muscle is dependent upon a zinc finger factor that binds to the G-rich box within the muscle-specific enhancer. J Biol Chem, 1998; 273: 484-494
30. Shimokawa T, Kato M, Ezaki O, Hashimoto S: Transcriptional regulation of muscle-specific genes during myoblast differentiation. Biochem Biophys Res Commun, 1998; 246: 287-292
31. Clesham GJ, Adam PJ, Proudfoot D et al: High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther, 1998; 5: 174-180
32. Stripecke R, Carmen Villacres M, Skelton D et al: Immune response to green fluorescent protein: implications for gene therapy. Gene Ther, 1999; 6: 1305-1312
33. Franz WM, Rothmann T, Frey N, Katus HA: Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters. Cardiovasc Res, 1997; 35: 560-566
34. Shield MA, Haugen HS, Clegg CH, Hauschka SD: E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol Cell Biol, 1996; 16: 5058-5068
35. Nakayama M, Stauffer J, Cheng J et al: Common core sequences are found in skeletal muscle slow- and fast-fiber-type-specific regulatory elements. Mol Cell Biol, 1996; 16: 2408-2417
36. Shi Q, Wang Y, Worton R: Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. Hum Gene Ther, 1997; 8: 403-410